Business Daily.
.
A+ R A-

Magellan Rx Management Offers Key Strategies to Manage PCSK9 Therapies

E-mail Print PDF
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Following the approval of evolocumab by the (FDA) yesterday, Magellan Rx Management today announced its ability to assist in appropriately managing the use of PCSK9 inhibitor medications.

imageimage
Grow Your Business with Times Media
Business Daily Media